Skip to main content
Contact
中
EN
search
Menu
About Us
Company
Milestones
Business Model
Organization
Team
Awards
Partners
R & D
PDSP Technology
Pipeline
BRM421
BRM424
BRM411
BRM412
BRM521
Patent Portfolio
Investors
Shareholder Information
Annual Report
Shareholding Structure
Shareholders Meeting
Important News
Stock Quotes
Stock Dividend
Financial Information
Financial Report
Monthly Revenue
ESG
Corporate Governance
Board of Directors
Committees
Corporate Governance Operations
Internal Audit
Risk Management
Major Internal Policies
Principles of Ethical Management
Stakeholder Engagement & Communication Achievements
Information Security Management
Sustainable Development
News & Events
News
Events
Human Resources
Bonuses & Benefits
Learning Development
Healthy Workplace
Join BRIM
search
Close Search
News & Events
News
All
2025
2024
2023
2022
2021
2022-04-04
Overcoming Challenges to Provide Affordable Treatments
2021-09-11
Haishan Jang, BRIM CEO, reveals the biggest challenges of orphan drug development
2021-06-29
BRIM Biotechnology’s lead candidate BRM421 for Dry Eye Disease shows promising results in Phase II clinical trials
« Previous
1
2
3
Close Menu
About Us
Company
Milestones
Business Model
Organization
Team
Awards
Partners
R & D
PDSP Technology
Pipeline
BRM421
BRM424
BRM411
BRM412
BRM521
Patent Portfolio
Investors
Shareholder Information
Annual Report
Shareholding Structure
Shareholders Meeting
Important News
Stock Quotes
Stock Dividend
Financial Information
Financial Report
Monthly Revenue
ESG
Corporate Governance
Board of Directors
Committees
Corporate Governance Operations
Internal Audit
Risk Management
Major Internal Policies
Principles of Ethical Management
Stakeholder Engagement & Communication Achievements
Information Security Management
Sustainable Development
News & Events
News
Events
Human Resources
Bonuses & Benefits
Learning Development
Healthy Workplace
Join BRIM
Contact
中
EN
